Previous Article | Next Article ![]()
Infect Immun, January 1998, p. 218-223, Vol. 66, No. 1
Department of Microbiology,
Received 27 June 1997/Returned for modification 25 August
1997/Accepted 23 October 1997
We investigated the importance of enterococcal aggregation
substance (AS) and enterococcal binding substance (EBS) in rabbit models of Enterococcus faecalis cardiac infections. First,
American Dutch belted rabbits were injected intraventricularly with
108 CFU and observed for 2 days. No clinical signs of
illness developed in animals given AS Recently, Enterococcus
faecalis and other enterococci have become increasingly recognized
as significant causes of nosocomial infections (23, 26, 27,
30). They are important causes of bacteremia, endocarditis, and
urinary tract infections. These organisms are also important because of
their increasing incidence of resistance to vancomycin and other
antibiotics and because of the potential of transferring antibiotic
resistance to other bacteria.
An important mechanism for horizontal transfer of antibiotic resistance
in enterococci is pheromone-inducible conjugation (10, 12,
34). The expression of conjugative transfer functions of plasmids
such as pCF10 (58 kb; encodes tetracycline resistance [12,
14]) and pAD1 (60 kb; encodes hemolysin and bacteriocin production [10, 31]) is induced by peptide pheromones
produced by recipient cells (13, 31, 34). The conjugation
gene products induced by pheromones include a cell surface adhesin,
aggregation substance (AS). This protein mediates the formation of
mating aggregates between donor and recipient cells by binding to a
cognate ligand on the recipient cell, enterococcal binding substance
(EBS) (13, 14). The prgB gene of pCF10 encodes
the AS protein, Asc10 (25), whose nucleotide and amino acid
sequences are highly similar to those of AS proteins encoded by other
pheromone plasmids (19, 20). The genetics of EBS are
complex, with multiple, unlinked insertion mutations required to
generate an EBS-negative phenotype (5, 12, 32). Lipoteichoic
acid (LTA) appears to be an important component of EBS (7, 15,
32).
Previous studies of the pathogenicity of E. faecalis have
shown that hemolysin contributes to the virulence of the organism in
animal models, including murine peritonitis, rabbit endophthalmitis, and rabbit endocarditis (9, 11, 21, 25, 26). In their study,
Chow et al. (9) also showed that AS contributed
significantly to the production of experimental endocarditis. Hemolysin
and AS were associated with increased mortality, and AS was associated with increased vegetation weight.
AS proteins of E. faecalis are thought to be virulence
factors in enterococcal infections by promoting binding to a variety of
eukaryotic cell surfaces (21, 25, 26). AS expression may be
induced in vivo by eukaryotic factors in serum (6). AS
contains amino acid motifs, Arg-Gly-Asp-Ser and Arg-Gly-Asp-Val, which
are found in fibronectin and other proteins and which mediate binding
to eukaryotic cell adhesion molecules of the integrin superfamily
(18, 21, 25). Soluble LTA inhibits aggregate formation and
may function as EBS (26). LTA from E. faecalis has previously been shown to induce both interleukin 1 This study was undertaken to evaluate the role of both AS and EBS in
two rabbit models of E. faecalis cardiac infections. Greater
insight into the role of these two factors in virulence may lead to
alternative methods of prophylaxis and treatment of resistant
enterococcal infections. Our studies indicate that the presence of both
cell surface components is associated with both increased mortality and
formation of vegetations.
(This work was presented in part at the 13th Lancefield International
Symposium on Streptococci and Streptococcal Diseases, Paris, France, 16 to 20 September 1996.)
Bacterial strains.
The bacterial strains used in these
studies were constructed and characterized previously (5, 26,
32). The EBS Intraventricular injection model of endocarditis.
Bacteria
were cultured to approximately 108 CFU/ml in a dialyzable
beef heart medium (28). Estimations of cell density were determined by absorbancy at 620 nm and verified by plate counts. Organisms were injected in 1-ml volumes of beef heart medium directly into the left ventricles of American Dutch belted rabbits purchased from Birchwood Farms, Grantsburg, Wis. After termination of the experiment, all animals were evaluated for needle puncture sites to
ensure that enterococci were injected into the left ventricle. Animals
were examined for 2 days for signs of infection, including fever,
diarrhea, clear amber urine, mottled faces, and death. Whether they
succumbed to infection or were euthanized after the 2-day test period,
all animals were examined for gross tissue effects due to infection.
All major organ systems, except for the nervous system, were examined.
Transaortic catheterization models of endocarditis.
New
Zealand White rabbits (Birchwood Farms) were anesthetized with ketamine
(25 mg/kg; Phoenix Pharmaceutical, Inc., St. Joseph, Mo.) and xylazine
(20 mg/kg; Phoenix), and the left carotid arteries in their necks were
exposed. Subsequently, catheters (outside diameter, 1.27 mm; Becton
Dickinson, Sparks, Md.) were inserted until the tubing was adjacent to
or transversed the aortic valve. In some experiments, catheters were
left in place for 2 h and then removed (animals remained
anesthetized for the entire 2-h period). In other experiments,
catheters were implanted and remained in place for the entire 3-day
test period. After catheterization, animals were closed with sutures
and then injected intravenously with enterococci. Animals were
monitored for 3 days and then their hearts and other organs were
examined grossly for signs of infection. During these experiments,
different catheter sizes were evaluated. Catheters of smaller diameters
did not lead to cardiac vegetations in experiments where catheters were
left in place for 2 h. Thus, we discontinued the use of these
materials.
0019-9567/98/$04.00+0
Copyright © 1998, American Society for Microbiology. All rights reserved.
Aggregation and Binding Substances Enhance
Pathogenicity in Rabbit Models of Enterococcus
faecalis Endocarditis
![]()
ABSTRACT
Top
Abstract
Introduction
Materials & Methods
Results
Discussion
References
EBS
organisms, and all survived. All rabbits given AS
EBS+ organisms developed signs of illness, including
significant pericardial inflammation, but only one of six died. All
animals given AS+ EBS
organisms developed
signs of illness, including pericardial inflammation, and survived. All
rabbits given AS+ EBS+ organisms developed
signs of illness and died. None of the rabbits receiving
AS+ EBS+ organisms showed gross pericardial
inflammation. The lethality and lack of inflammation are consistent
with the presence of a superantigen. Rabbit and human lymphocytes were
highly stimulated in vitro by cell extracts, but not cell-free culture
fluids, of AS+ EBS+ organisms. In contrast,
cell extracts from AS
EBS
organisms weakly
stimulated lymphocyte proliferation. Culture fluids from human
lymphocytes stimulated with AS+/EBS+
enterococci contained high levels of gamma interferon and tumor necrosis factor alpha (TNF-
) and TNF-
, which is consistent with functional stimulation of T-lymphocyte proliferation and macrophage activation. Subsequent experiments examined the abilities of the same
strains to cause endocarditis in a catheterization model. New Zealand
White rabbits underwent transaortic catheterization for 2 h, at
which time catheters were removed and animals were injected with 2 × 109 CFU of test organisms. None of the animals given
AS
EBS
organisms developed vegetations or
showed autopsy evidence of tissue damage. Rabbits given
AS
EBS+ or AS+ EBS
organisms developed small vegetations and had splenomegaly at autopsy.
All rabbits given AS+ EBS+ organisms developed
large vegetations and had splenomegaly and lung congestion at autopsy.
Similar experiments that left catheters in place for 3 days revealed
that all rabbits given AS
EBS
or
AS+ EBS+ organisms developed vegetations, but
animals given AS+ EBS+ organisms had larger
vegetations and autopsy evidence of lung congestion. These experiments
provide direct evidence that these two cell wall components play an
important role in the pathogenesis of endocarditis as well as in
conjugative plasmid transfer.
![]()
INTRODUCTION
Top
Abstract
Introduction
Materials & Methods
Results
Discussion
References
and tumor necrosis factor alpha (TNF-
) production from macrophages
(7).
![]()
MATERIALS AND METHODS
Top
Abstract
Introduction
Materials & Methods
Results
Discussion
References
mutant INY3000 was generated by
Tn916 insertion in the E. faecalis 0G1SSp
chromosome (32). Plasmid pINY1801 (26) contains a
fragment of pCF10 cloned into shuttle vector pWM401 (35) and
confers constitutive expression of Asc10.
and AS
EBS+
organisms formed aggregates.
Lymphocyte mitogencity. Rabbit splenocytes and human peripheral blood mononuclear cells were cultured in RPMI cell culture medium in quadruplicate on 96-well microtiter plates (2 × 105 lymphocytes/well/200 µl) (2). Cultures were incubated at 37°C in the presence of 7% CO2 with serial 10-fold dilutions of enterococcal-cell extracts or supernatants. Cells incubated with 1 µg of toxic shock syndrome toxin-1 (TSST-1) served as the positive control for T-cell proliferation. Cells incubated in medium alone served as the negative control. After 72 h of incubation, cells were pulsed for 18 h with [3H]thymidine (1 µCi/well; Amersham Corp., Arlington Heights, Ill.). Cells were harvested onto glass fiber filters, and the counts per minute due to [3H]thymidine incorporation into DNA were measured by scintillation counting.
Cytokine assays.
Cell-free culture fluids from human
lymphocytes that had been stimulated for 4 days with enterococcal
fractions, TSST-1, or negative controls were evaluated for gamma
interferon and TNF-
as a measure of significant CD4+
T-cell stimulation. The same culture fluids were evaluated for TNF-
as a functional measure of macrophage activation. For all assays,
lymphocyte culture fluids from four comparably treated wells were
pooled. All assays were performed with enzyme-linked immunosorbent
assay (ELISA) kits purchased from R & D Systems, Inc., Plymouth, Minn.
Assays were performed as suggested by the manufacturer.
Enterococcal culture supernatants and cell extracts.
E.
faecalis AS+ EBS+ and AS
EBS
organisms were cultured in 100 ml of dialyzable beef
heart medium overnight at 37°C. Stationary-phase cultures were
centrifuged at 500 × g for 15 min, and supernatants were filtered through 0.45-µm-pore-size filters (Costar Scientific, Cambridge, Mass.). Supernatants were treated with 400 ml of absolute ethanol at 4°C to precipitate proteins.
Statistics. Fisher's exact probability test was used to evaluate significant differences in survival rates among groups. Vegetations were considered 1+ when they were pinpoint in size and only one or two were present. In contrast, 3+ vegetations were large (up to 5 mm in diameter), often obstructing the ascending aorta, and typically numerous. Intermediate vegetations were scored 2+. Vegetation quality was scored by at least two individuals in a blinded fashion.
| |
RESULTS |
|---|
|
|
|---|
First, we assessed the virulence of various strains of E. faecalis by injecting approximately 108 CFU into the
left ventricles of American Dutch belted rabbits and observing them for
2 days for signs of illness and death (Table 1). AS
EBS
strain INY3000(pWM401) caused clinical signs in zero of six animals, and none of the animals died. Upon autopsy, no signs of infections were
seen. AS
EBS+ strain OG1SSp(pWM401) caused
clinical signs in six of six rabbits, but only one of six died. Autopsy
evaluations of these animals revealed highly significant pericardial
inflammation, as determined by direct microscopic examination of fluid
for polymorphonuclear leukocytes (PMNs). AS+
EBS
strain INY3000(pINY1801) caused clinical signs in
three of three rabbits, and none died. As with AS
EBS+ organisms, rabbits which had received AS+
EBS
organisms showed significant pericardial
inflammation. AS+ EBS+ strain OG1SSp(pINY1801)
caused clinical signs in nine of nine animals, and all of the animals
died. Necropsy analyses of these animals indicated no evidence of
pericardial inflammation. Rather, grossly observable destruction of
both myocardial and lung tissues was evident. These results indicate
that in this model, strains which lack AS and EBS are relatively
avirulent compared to strains that possess both of these traits and
strains which possess either AS or EBS are intermediate in virulence by
comparison. Furthermore, this experiment suggested that the
AS+ EBS+ strain produced factors that prevented
pericardial inflammation, either through destruction of inflammatory
cells or by preventing PMN influx into the site of infection.
|
Since the E. faecalis strains used in this study lack
hemolysin and do not make known factors that are toxic to PMNs, it was hypothesized that AS+ EBS+ organisms made one
or more factors that induced lethality and prevented PMN influx into
the heart. Superantigens made by both Staphylococcus aureus
and group A streptococci have previously been shown to cause high-level
release of both TNF-
and -
from macrophages and T cells,
respectively, both of which cause capillary leak and down regulate
chemotactic receptors on PMNs (16, 17, 24). The latter
effect of superantigens has previously been shown in in vitro systems
to prevent chemotaxis of PMNs and has been proposed in part to explain
the lack of inflammation seen at sites of infection during both
staphylococcal and streptococcal toxic shock syndromes (TSS) (3,
29). Thus, it was possible that AS+ EBS+
E. faecalis organisms made superantigen-like molecules that
had a similar lethal and antichemotactic effect.
In order to test for superantigen-like molecules, culture supernatants
and cell extracts from both AS+ EBS+ and
AS
EBS
organisms were evaluated for the
ability to stimulate rabbit and human lymphocytes. Cell-free culture
fluids from both organisms failed to stimulate either rabbit or human
lymphocytes (data not shown). In contrast, TSST-1 (used as a positive
control) caused highly significant proliferation. Cell extracts of
AS+ EBS+ organisms also caused significant
lymphocyte proliferation in both species (Tables
2 and 3).
As indicated in Table 2, AS+ EBS+ organisms
induced the highest proliferation of rabbit lymphocytes at the 1:1,000
dilution of cell extract, with activity comparable to that of the
superantigen TSST-1 (used as a positive control). In contrast, cell
extracts from AS
EBS
organisms caused
significantly less rabbit lymphocyte proliferation at all of the
dilutions tested.
|
|
AS+ EBS+ organisms also caused significant
human peripheral blood lymphocyte proliferation, with the peak
proliferation occurring with the 1:10 diluted extract. The response
seen at that dilution was again comparable to the response seen with
TSST-1. Extracts from AS
EBS
organisms
failed to stimulate proliferation of human lymphocytes. In both rabbit
and human test systems, high doses of extract caused inhibition of
lymphocyte proliferation.
Superantigenic stimulation of lymphocytes results in massive releases
of cytokines, such as TNF-
from macrophages and TNF-
and gamma
interferon from CD4+ T cells (16, 17, 24).
Release of these cytokines can also be used as an indicator of whether
the lymphocyte proliferation that occurred was the result of functional
activation of T cells and macrophages. The 1:10 diluted cell extract
from AS+ EBS+ organisms, which was the dilution
which induced maximal human lymphocyte proliferation, caused highly
significant release of each of these three human cytokines (Table
4). Thus, cell extracts of
AS+ EBS+ organisms induced T-cell
proliferation, with consequent release of TNF-
and gamma interferon
and activation of macrophages to release TNF-
.
|
Next, we investigated the abilities of the same strains to cause
cardiac vegetations in a rabbit catheterization model. New Zealand
White rabbits were anesthetized, and each had a catheter placed across
the aortic valve via the left carotid artery. The catheter was left in
place for approximately 2 h and subsequently removed prior to
intravenous injection of 2 × 109 CFU of test
organisms. The animals were sacrificed on day 3 and examined for
cardiac vegetations or other organ damage (Table 5). The AS
EBS
strain produced vegetations in zero of four animals
and affected no other organ. Two additional animals given 5 × 109 CFU of the AS
EBS
strain
had identical negative results. The AS
EBS+
and AS+ EBS
strains produced very small
cardiac vegetations and enlarged spleens in all of the animals tested
(four each). The AS+ EBS+ strain produced large
vegetations, and five of the five animals tested had enlarged spleens
and lung congestion. Two additional animals given 5 × 109 or 2 × 1010 CFU of the
AS+ EBS+ strain succumbed overnight and showed
extensive lung necrosis. As in the previous experiment, these results
show that in this model, strains which possess both AS and EBS are more
virulent and have an enhanced ability to cause cardiac vegetations
compared to those of strains which lack AS and EBS. Strains with either AS or EBS are virulent and can produce vegetations but to a lesser degree than AS+ EBS+ strains can.
|
We also investigated the ability of some of these organisms to cause
endocarditis in the same model, modified by leaving the catheter in
place for the 3-day observation period. Rabbits were prepared in a
similar fashion, except that the catheter was placed through the aortic
valve and not removed prior to injection of 2 ml of test organism at
approximately 2 × 109 CFU. The AS
EBS
strain caused small (1+) vegetations in three of four
animals. The other animal, whose myocardium had been completely
penetrated by the catheter, had very large vegetations. The effects on
other organs were minimal to none in all of these animals. The
AS+ EBS+ strain caused very large (3+)
vegetations and lung congestion in four of four animals. These
experiments, taken together with the previous results, indicate that
both AS and EBS are important in the ability of this organism to cause
cardiac vegetations; however, leaving transaortic catheters in place
during infection may artificially enhance the capacities of test
strains to cause cardiac vegetations in this model.
| |
DISCUSSION |
|---|
|
|
|---|
Here, two models for the study of E. faecalis endocarditis were established. Experiments demonstrated that both AS and EBS were important in establishing cardiac infections.
In the first model, organisms were injected directly into the left
ventricle of the heart. Although this is not the standard model for the
induction of endocarditis in rabbits, the experiment clearly showed
differences in virulence among enterococcal strains. The most
interesting aspect was the observation that rabbits injected with
AS+ EBS+ organisms succumbed, whereas rabbits
given AS
EBS
organisms showed no signs of
infection. It is clear from these studies that both enterococcal cell
surface receptors for mating pair formation contribute to virulence.
Animals that received AS+ EBS+ organisms
developed a TSS-like illness and succumbed with major destruction of
heart and lung tissues but without signs of pericardial inflammation.
In TSS, a similar lack of inflammation has previously been proposed to
result from massive TNF release as a result of superantigen activity,
with consequent down regulation of PMN chemotactic receptors and
failure of PMNs to migrate into the infected area (17, 18,
24). AS+ EBS+ organisms may have made a
superantigen that caused some of the biological effects seen. This is
consistent with the highly significant rabbit and human lymphocyte
proliferation induced by AS+ EBS+ organisms,
which was comparable to that seen with TSST-1. Furthermore, lymphocyte
proliferation involved T cells since high levels of TNF-
and gamma
interferon were released, a result consistent with that expected for
T-cell superantigens (16, 17). This is also consistent with
three cultures of enterococci submitted to us from blood samples of
patients with TSS for which enterococci were thought to be the cause.
It is likely that the T-cell stimulatory factors present in
AS+ EBS+ organisms but not in AS
EBS
organisms were either aggregation or binding
substances or more likely both, since these organisms have the same
genetic background but differ in those two factors. A previous study of
enterococcal LTA, which is likely to be analogous to enterococcal EBS,
showed that LTA causes significant TNF-
release (7). It
is unlikely that the effects observed were due to the toxic effects of
peptidoglycan since both organisms have this molecule. It is also
possible that the observed effects of the AS and EBS phenotypes on
virulence are due to an indirect effect of these components on the
expression or activities of other surface factors. However, the data
presented here, along with previous results (9, 21, 25),
clearly demonstrate major effects of AS and EBS on enterococcal
virulence.
In the same intraventricular injection model, both AS+
EBS
and AS
EBS+ organisms
showed intermediate virulence, indicating the importance of both
factors in complete activity. Finally, organisms that lacked both
factors appeared to be cleared very rapidly from rabbits so that no
evidence of infection was observable.
In the second model, animals were injected with the same enterococcal
strains after transaortic catheterization. This model has previously
been used by other investigators to study bacterial endocarditis
(4, 9) and to demonstrate the importance of AS in virulence
(9). For example, in a study by Chow et al. (9),
it was demonstrated that both AS and hemolysin contributed to increased
mortality in experimental endocarditis and that AS was associated with
increased vegetation weight. In our studies, four major observations
were made. First, inoculum size was important, particularly in the case
of AS+ EBS+ organisms. For example, an
administration of 5 × 109 or greater CFU of the
AS+ EBS+ strains resulted in death, whereas
doses of 2 × 109 CFU or below did not. This high-dose
effect is likely comparable to that seen when organisms were injected
intraventricularly at the 108 dose since similar gross
pathological changes were seen. In contrast, AS
EBS
organisms did not cause lethality at any dose,
similar to what was seen in our previous experiments. Second, catheter
size was important. An administration of AS+
EBS+ organisms at doses of 2 × 109 CFU
intravenously to rabbits without catheters or with
small-internal-diameter catheters failed to result in signs of
infection. Third, continuous exposure of rabbits to catheters resulted
in greater sizes and numbers of vegetations in the heart and rendered
AS
EBS
organisms capable of causing
endocardial disease. Lastly, AS+ EBS+ organisms
caused more significant cardiac infections, typified by large and
numerous vegetations, than did either organisms having only one of the
two factors or organisms lacking both. Organisms having either AS or
EBS were intermediate in the ability to cause cardiac vegetations.
Thus, we confirmed the findings of Chow et al. (9)
concerning the role of AS in virulence of E. faecalis but
also extended those findings to include the combination of AS and EBS.
It is also important that Chow et al. (9) demonstrated the
importance of hemolysin in disease. The organisms used in our studies
lacked hemolysin production.
The heart valve vegetations characteristic of both clinical endocarditis in humans and experimental endocarditis in animals result from a complex series of interactions among damaged cardiac endothelium, bacteria, platelets, and serum factors (1). Our results also suggest that a cell surface-associated bacterial superantigen or another type of mitogenic factor contributed to the lethality observed after direct injection of AS+ EBS+ organisms into the heart (Table 1) and in some catheterized animals which experienced severe endocarditis and death after infection with the same strain (Table 5). Based on the data obtained thus far, it is likely that several potential virulence properties, including adherence, resistance to killing by phagocytes, and production of toxins, are related to the AS and EBS phenotypes of E. faecalis. Further biochemical and genetic analyses of these surface components are required to define the molecular basis for the correlation of the AS+ EBS+ phenotype with virulence in this system. Finally, it should be noted that the AS+ strains used here are recombinant strains which express Asc10 constitutively. Our recent evidence (unpublished data) suggests that a host factor present in both rabbit blood and human blood can increase the expression of Asc10 in cells carrying wild-type pCF10. This is consistent with a previous report of in vivo induction of AS expression (6).
Thus, in two models of enterococcal infections, organisms with both AS
and EBS exhibited the greatest ability to cause disease, with
AS+ EBS
and AS
EBS+
organisms demonstrating intermediate virulence and AS
EBS
organisms lacking the ability to cause disease
(except in instances where catheters remained in rabbits). It is,
however, important to remember that available data indicate that some
clinical isolates of enterococci from patients with endocarditis
apparently lack AS. Therefore, other factors must also play important
roles in the clinical setting. One possible example of such a factor is the chromosomally encoded EfaA antigen (22), which is
similar in sequence to the FimA adhesion protein, previously shown to contribute to virulence in Streptococcus parasanguis
experimental endocarditis (8, 33).
Future studies are directed toward evaluating AS and EBS, both alone
and in combination, for superantigen activity. In addition, we are
attempting direct purification of the putative superantigen from the
AS+ EBS+ strain. Final clarification of whether
the purified substance is a superantigen will require the determination
of whether the factor has the following defining superantigen
properties: (i) activation of T cells independent of antigen
specificity, (ii) ability to activate T cells dependent on the variable
region of the
chain of the T-cell receptor, and (iii) requirement
for presentation to T cells via antigen-presenting cells without
restriction.
| |
ACKNOWLEDGMENTS |
|---|
This work was supported by USPHS research grant HL51987 from the National Heart, Lung, and Blood Institute. A. P. Assimacopoulos was supported by USPHS training grant 2-T32-HD-07381, and M. M. Dinges was supported by USPHS training grant 2-T32-AI-07421.
Melodie Bahan is gratefully acknowledged for typing the manuscript.
| |
FOOTNOTES |
|---|
* Corresponding author. Mailing address: Department of Microbiology, University of Minnesota Medical School, Minneapolis, MN 55455-0312. Phone: (612) 624-9471. Fax: (612) 626-0623. E-mail: pats{at}lenti.med.umn.edu.
Editor: P. E. Orndorff
| |
REFERENCES |
|---|
|
|
|---|
| 1. |
Baddour, L. M.
1994.
Virulence factors among gram-positive bacteria in experimental endocarditis.
Infect. Immun.
62:2143-2148 |
| 2. |
Barsumian, E. L.,
P. M. Schlievert, and D. W. Watson.
1978.
Nonspecific and specific immunological mitogenicity by group A streptococcal pyrogenic exotoxins.
Infect. Immun.
22:681-688 |
| 3. |
Bartlett, P.,
A. L. Reingold,
D. R. Graham,
B. B. Dan,
D. S. Selinger,
G. W. Tank, and K. A. Wichterman.
1982.
Toxic shock syndrome associated with surgical infections.
JAMA
247:1448-1450 |
| 4. |
Bayer, A. S., and J. Tu.
1990.
Chemoprophylactic efficacy against experimental endocarditis caused by -lactamase-producing, aminoglycoside-resistant enterococci is associated with prolonged serum inhibitory activity.
Antimicrob. Agents Chemother.
34:1068-1074 |
| 5. |
Bensing, B. A., and G. M. Dunny.
1993.
Cloning and molecular analysis of genes involved in expression of binding substance, the recipient-encoded receptor(s) mediating mating aggregate formation in Enterococcus faecalis.
J. Bacteriol.
175:7421-7429 |
| 6. | Bensing, B. A., D. A. Manias, and G. M. Dunny. 1997. Pheromone cCF10-encoded regulatory molecules act post-transcriptionally to activate expression of downstream conjugation factors. Mol. Microbiol. 24:295-308[Medline]. |
| 7. |
Bhakdi, S.,
T. Klonish,
T. Nuber, and W. Fischer.
1991.
Stimulation of monokine production by lipoteichoic acids.
Infect. Immun.
59:4614-4620 |
| 8. | Burnette-Curley, D., V. Wells, H. Viscount, C. L. Munro, J. C. Fenno, P. Fives-Taylor, and F. L. Macrina. 1995. FimA, a major virulence factor associated with Streptococcus parasanguis endocarditis. Infect. Immun. 63:4669-4674[Abstract]. |
| 9. |
Chow, J. W.,
L. A. Thal,
M. B. Perri,
J. A. Vazquez,
S. M. Donabedian,
D. B. Clewell, and M. J. Zervos.
1993.
Plasmid-associated hemolysin and aggregation substance production contribute to virulence in experimental enterococcal endocarditis.
Antimicrob. Agents Chemother.
37:2474-2477 |
| 10. | Clewell, D. B. 1993. Bacterial sex pheromone-induced plasmid transfer. Cell 73:9-12[Medline]. |
| 11. | Coque, T. M., J. E. Patterson, J. M. Steckelberg, and B. E. Murray. 1995. Incidence of hemolysin, gelatinase, and aggregation substance among enterococci isolated from patients with endocarditis and other infections and from feces of hospitalized and community-based persons. J. Infect. Dis. 171:1223-1229[Medline]. |
| 12. | Dunny, G., C. Funk, and J. Adsit. 1981. Direct stimulation of the transfer of antibiotic resistance by sex pheromones in Streptococcus faecalis. Plasmid 6:270-278[Medline]. |
| 13. | Dunny, G. M., R. A. Craig, R. L. Carron, and D. B. Clewell. 1979. Plasmid transfer in Streptococcus faecalis: production of multiple pheromones by recipients. Plasmid 2:454-465[Medline]. |
| 14. |
Dunny, G. M.,
B. A. B. Leonard, and P. J. Hedberg.
1995.
Pheromone-inducible conjugation in Enterococcus faecalis: interbacterial and host-parasite chemical communication.
J. Bacteriol.
177:871-876 |
| 15. |
Ehrenfeld, E. E.,
R. E. Kessler, and D. B. Clewell.
1986.
Identification of pheromone-induced surface proteins in Streptococcus faecalis and evidence of a role for lipoteichoic acid in the formation of mating aggregates.
J. Bacteriol.
168:6-12 |
| 16. | Fast, D. J., P. M. Schlievert, and R. D. Nelson. 1988. Nonpurulent response to toxic shock syndrome toxin-1 producing Staphylococcus aureus: relationship to toxin-stimulated production of tumor necrosis factor. J. Immunol. 140:949-953[Abstract]. |
| 17. |
Fast, D. J.,
P. M. Schlievert, and R. D. Nelson.
1989.
Toxic shock syndrome-associated staphylococcal and streptococcal pyrogenic toxins are potent inducers of tumor necrosis factor production.
Infect. Immun.
57:291-294 |
| 18. | Galli, D., F. Lottspeich, and R. Wirth. 1990. Sequence analysis of Enterococcus faecalis aggregation substance encoded by the sex pheromone plasmid pAD1. Mol. Microbiol. 4:895-904[Medline]. |
| 19. |
Galli, D., and R. Wirth.
1991.
Comparative analysis of Enterococcus faecalis sex pheromone plasmids identifies a single homologous DNA region which codes for aggregation substance.
J. Bacteriol.
173:3029-3033 |
| 20. | Hirt, H., G. Wanner, D. Galli, and R. Wirth. 1993. Biochemical, immunological, and ultrastructural characterization of aggregation substances encoded by Enterococcus faecalis sex-pheromone plasmids. Eur. J. Biochem. 211:711-716[Medline]. |
| 21. |
Kreft, B.,
R. Marre,
U. Schramm, and R. Wirth.
1992.
Aggregation substance of Enterococcus faecalis mediates adhesion to cultured renal tubular cells.
Infect. Immun.
60:25-30 |
| 22. | Lowe, A. M., P. A. Lambert, and A. W. Smith. 1995. Cloning of an Enterococcus faecalis endocarditis antigen: homology with adhesins from some oral streptococci. Infect. Immun. 63:703-706[Abstract]. |
| 23. | Martone, W. J., W. R. Jarvis, D. H. Culver, and R. W. Haley. 1992. Incidence and nature of endemic and epidemic nosocomial infections, p. 577-596. In V. Bennet, and P. S. Brachman (ed.), Hospital infections. Little, Brown, & Co., Boston, Mass. |
| 24. | Nelson, R. D., D. J. Fast, and P. M. Schlievert. 1990. Pyrogenic toxin stimulation of TNF production by human mononuclear leukocytes and effect of TNF on neutrophil chemotaxis, p. 177-186. In B. Bonavida, and G. Granger (ed.), Tumor necrosis factor: structure, mechanism of action, role in disease and therapy. S. Karger, Basel, Switzerland. |
| 25. | Olmsted, S. B., G. M. Dunny, S. L. Erlandsen, and C. L. Wells. 1994. A plasmid-encoded surface protein on Enterococcus faecalis augments its internalization by cultured intestinal epithelial cells. J. Infect. Dis. 170:1549-1556[Medline]. |
| 26. |
Olmsted, S. B.,
S.-M. Kao,
L. J. van Putte,
J. C. Gallo, and G. M. Dunny.
1991.
Role of the pheromone-inducible surface protein Asc10 in mating aggregate formation and conjugal transfer of the Enterococcus faecalis plasmid pCF10.
J. Bacteriol.
173:7665-7672 |
| 27. | Schaberg, D. R., D. H. Culver, and R. P. Gaynes. 1991. Major trends in the microbial ecology of nosocomial infection. Am. J. Med. 91:72S-75S[Medline]. |
| 28. | Schlievert, P. M., K. N. Shands, B. B. Dan, G. P. Schmid, and R. D. Nishimura. 1981. Identification and characterization of an exotoxin from Staphylococcus aureus associated with toxic shock syndrome. J. Infect. Dis. 143:509-516[Medline]. |
| 29. | Schlievert, P. M., A. P. Assimacopoulos, and P. P. Cleary. 1996. Severe invasive group A streptococcal disease: clinical description and mechanisms of pathogenesis. J. Lab. Clin. Med. 127:13-22[Medline]. |
| 30. | Tailor, S. A. N., E. M. Bailey, and M. J. Rybak. 1993. Enterococcus, an emerging pathogen. Ann. Pharmacother. 27:1231-1242[Abstract]. |
| 31. |
Tomich, P. K.,
F. Y. An,
S. P. Damle, and D. B. Clewell.
1979.
Plasmid-related transmissibility and multiple drug resistance in Streptococcus faecalis subspecies zymogenes strain DS16.
Antimicrob. Agents Chemother.
15:828-830 |
| 32. | Trotter, K. M., and G. M. Dunny. 1990. Mutants of Enterococcus faecalis deficient as recipients in mating with donors carrying pheromone-inducible plasmids. Plasmid 24:57-67[Medline]. |
| 33. | Viscount, H. B., C. L. Munro, D. Burnette-Curley, D. L. Peterson, and F. L. Macrina. 1997. Immunization with FimA protects against Streptococcus parasanguis endocarditis in rats. Infect. Immun. 65:994-1002[Abstract]. |
| 34. | Wirth, R. 1994. The sex pheromone system of Enterococcus faecalis: more than just a plasmid-collection mechanism? Eur. J. Biochem. 222:235-246[Medline]. |
| 35. |
Wirth, R.,
F. Y. An, and D. B. Clewell.
1986.
Highly efficient protoplast transformation system for Streptococcus faecalis and a new Escherichia coli-S. faecalis shuttle vector.
J. Bacteriol.
165:831-836 |
This article has been cited by other articles:
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Copyright © 2009 by the American Society for Microbiology. For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»